Canopy Rivers Appoints Former OMERS Venture Capital Specialist as President

Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) today announced that Narbe Alexandrian has been appointed as President of the Company, effective immediately. In this role, Narbe will lead the corporate development initiatives as well as manage the day-to-day business of the Company. He will report directly to Bruce Linton, Chief Executive Officer.

Read More
Canopy Rivers Targets CBD Health and Wellness Market With Investment in Greenhouse Juice Company

Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV:RIV) today announced its investment in Greenhouse Juice Company (“Greenhouse”), a dynamic plant-based food and beverage company. Canopy Rivers has committed $9 million in a convertible debt financing package (the “Financing”) that includes secured and unsecured debt, warrant coverage, and board representation rights. Proceeds from this financing will be used to supplement Greenhouse’s national expansion and initiatives for the development of natural health and wellness beverages infused with cannabidiol (“CBD”).

Read More
Canopy Rivers Announces Investment in Technology Driven Data Company Headset

Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV:RIV) is pleased to announce it has completed an equity investment in Headset, Inc. (“Headset”), a data and analytics service provider for the cannabis industry. Canopy Rivers subscribed for C$4,084,500 of Series A Preferred Shares in Headset, representing the Company’s first entry into a technology-focused cannabis vertical.

Read More
Alessandra Hechanova
Canopy Rivers Announces $80 Million Bank Debt Facility at PharmHouse

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) today announced that its 49%-owned joint venture PharmHouse Inc. (“PharmHouse”) has entered into a syndicated credit facility (the “Credit Facility”) with the Bank of Montreal (“BMO”), as agent and lead lender, and with Canadian Imperial Bank of Commerce and Concentra Bank as lenders (together with BMO, the “Lenders”).

Read More
Canopy Rivers Portfolio Company TerrAscend Gains Traction in New Jersey Medical Cannabis Market

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) today provided an update that an entity controlled by its portfolio company TerrAscend Corp. (“TerrAscend”) (CSE: TER; OTCQX: TRSSF), NETA NJ LLC (“NETA”), has been selected by the State of New Jersey Department of Health to apply for final approval to operate a vertically integrated Alternative Treatment Center (ATC), which would permit it to cultivate, process and sell medical cannabis in the state.

Read More
Canopy Growth and Canopy Rivers Announce Completion of TerrAscend Restructuring

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth") and Canopy Rivers Inc. ("Canopy Rivers") (TSXV: RIV) are pleased to announce the closing of the previously announced restructuring transaction with TerrAscend Corp. ("TerrAscend") (CSE: TER) pursuant to which TerrAscend restructured its share capital by way of a plan of arrangement under the Business Corporations Act (Ontario) (the "Arrangement").

Read More
Canopy Rivers Reports Second Quarter Financial Highlights and Provides Corporate Update

Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) today released its financial results for the three and six months ended September 30, 2018. The Company's full Management's Discussion and Analysis and unaudited condensed interim consolidated financial statements for the three and six months ended September 30, 2018 are available on SEDAR (www.sedar.com) and posted on the Company’s website at www.canopyrivers.com/financials.

Read More
Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse

anopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) is pleased to announce it has, through its wholly-owned subsidiary Canopy Rivers Corporation, entered into an incremental funding agreement with its joint venture partner PharmHouse Inc. (“PharmHouse”) and amended the terms of the Company’s global non-competition agreement with joint venture partner, 2615975 Ontario Limited (the “Joint Venture Partner”), to include additional rights in favour of the Company in the event the Joint Venture Partner commences operations in the U.S. cannabis market.

Read More
Canopy Rivers Portfolio Company Radicle Receives Licence From Health Canada to Commence Sales of Premium Craft Cultivated Product

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV:RIV) congratulates its portfolio company, Radicle Medical Marijuana Inc. (“Radicle”), on receiving its production and sales licence from Health Canada. The licence will allow Radicle to supply and sell finished cannabis products for both the medical and adult-use market in Canada. 

Read More
Canopy Rivers Announces Significant Contract Manufacturing Agreement Between Portfolio Partners PharmHouse and TerrAscend

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV:RIV) is pleased to announce PharmHouse Inc. (“PharmHouse”), has entered into an offtake agreement (the “Agreement”) to supply TerrAscend Canada Inc. (“TerrAscend Canada”), a wholly-owned subsidiary of TerrAscend Corp. (“TerrAscend”) (CSE:TER),  with cannabis products from 20% of the flowering space at its 1.3 million square foot greenhouse facility until December 31, 2021.

Read More
Canopy Rivers Announces Significant Increase in Health Canada Licensed Infrastructure at Vert Mirabel

Canopy Rivers Inc. (the “Company”) (TSXV: RIV) is pleased to announce that its investment portfolio company, Les Serres Vert Cannabis Inc. (“Vert Mirabel”), a joint venture with Canopy Growth Corporation (TSX:WEED, NYSE:CGC) (“Canopy Growth”) and Les Serres Stéphane Bertrand (“Bertrand”) based in Mirabel, Quebec, has received a licence amendment from Health Canada that significantly increases Vert Mirabel’s greenhouse production footprint, which now includes 525,000 sq. ft. of licensed operating space available for cannabis production.

Read More
Canopy Rivers Inc. Announces Completion of Its Qualifying Transaction

Canopy Rivers Inc. (the “Company”) (formerly AIM2 Ventures Inc. (“AIM2”)) is pleased to announce that it has completed its previously announced business combination (the “Transaction”) with Canopy Rivers Corporation (“Canopy Rivers”) as well as the exchange of the subscription receipts (the “Subscription Receipts”) issued in connection with Canopy Rivers’ previously announced $104 million private placement offering (the “Offering”) co-led by CIBC Capital Markets and GMP Securities L.P., as joint book-runners, and together with Eight Capital as co-lead agents.

Read More
Canopy Rivers and AIM2 Announce Shareholder Approval of Qualifying Transaction

Canopy Rivers Corporation (“Canopy Rivers”) and AIM2 Ventures Inc. (TSXV:AIMB.P) (“AIM2”) are pleased to announce that the shareholders of the respective companies have overwhelmingly voted in favour of all matters in connection with the previously announced business combination involving Canopy Rivers and AIM2 that will result in a reverse take-over of AIM2 by Canopy Rivers (the “Transaction”) and will constitute AIM2’s “Qualifying Transaction” (as such term is defined in Policy 2.4 of the TSX Venture Exchange (the “TSXV”) Corporate Finance Manual).

Read More